Crexendo Q2: Software Growth Plunges to 5%, Breaking the Core Thesis

What happened

Crexendo reported Q2 2026 revenue of $24.6M, up 49% year-over-year, but organic growth was only 7% and software revenue grew just 5%, far below the ~30% growth seen in 2025. Profitability improved with gross margin of 65.9%, EBITDA margin of 12.6%, and free cash flow margin of 10.2%, partly driven by the ESI acquisition integration. However, the sharp deceleration in the high-margin software segment directly contradicts the master report's assumption of sustained ≥20% software growth and triggers a key thesis breaker. The reported revenue growth is heavily acquisition-driven, masking underlying organic weakness and raising questions about the durability of the software-led narrative. While the article maintains a Strong Buy rating, the deteriorating growth engine suggests the optimistic stance may be unwarranted.

Implication

The master report's thesis breaker of software growth below 15% for two consecutive quarters appears to have been triggered, with Q2 2026 growth of just 5%. Organic consolidated growth of only 7% indicates that acquisitions are masking fundamental weakness, and the company may struggle to justify its premium valuation without strong organic expansion. Margin improvement, while positive, does not compensate for the loss of top-line growth in a richly valued stock trading at ~36x EV/EBITDA. The current share price likely does not reflect this deterioration, and risk/reward has worsened significantly. Investors should require a meaningful price reset toward the bear case of $5 or concrete evidence of AI-driven ARPA uplift and organic software re-acceleration before considering new positions.

Thesis delta

The prior thesis was built on ~30% software growth, but Q2 2026 reveals a dramatic slowdown to just 5%, invalidating the core growth assumption. The investment case shifts from a high-growth software platform to a slower, acquisition-dependent company with improving margins but questionable organic momentum. The rating should move from WAIT to AVOID or SELL until the software segment demonstrates sustainable re-acceleration.